Oxcitas
Oxcitas is an Anglo-Spanish health technology company that develops proprietary digital platforms using machine learning, artificial intelligence, and systems biology to understand and decelerate the ageing process. Their core platforms, PREDICT-oRx® and DISCOVER-oRx®, are designed to assess, quantify, and predict changes in biological age in response to treatment interventions. These flexible, tailor-made solutions combine genotypic, phenotypic, and metabolic signatures to stratify patient populations, optimize treatment impacts, and serve as prognostic tools. Oxcitas focuses on clinical areas including pulmonary, metabolic, cardiovascular diseases, and CNS diseases and disorders, aiming to impact human longevity by providing digital tools to demonstrate the efficacy of interventions on the biology of ageing.
Oxcitas
Oxcitas is an Anglo-Spanish health technology company that develops proprietary digital platforms using machine learning, artificial intelligence, and systems biology to understand and decelerate the ageing process. Their core platforms, PREDICT-oRx® and DISCOVER-oRx®, are designed to assess, quantify, and predict changes in biological age in response to treatment interventions. These flexible, tailor-made solutions combine genotypic, phenotypic, and metabolic signatures to stratify patient populations, optimize treatment impacts, and serve as prognostic tools. Oxcitas focuses on clinical areas including pulmonary, metabolic, cardiovascular diseases, and CNS diseases and disorders, aiming to impact human longevity by providing digital tools to demonstrate the efficacy of interventions on the biology of ageing.